Highlights d Regulome analysis reveals a spectrum of molecular programs for human ILC1-NK cells d Conserved regulatory schemes for localization-function shared by NK and T cells d TCF1-MYC enforce progenitor-like, lymph node localization modules d PRDM1-ZEB2-MAF dominate effector and non-lymphoid localization programs
INTRODUCTION
Natural killer (NK) cells provide protection from viral infections or cancer via their cytolytic function and interferon gamma (IFNg) production. A major clinical goal is to harness these NK cell functions for tumor immunotherapy (Baggio et al., 2017; Johnson and Miller, 2018; Romee et al., 2016) . In addition, NK cells have been implicated in the control of HIV infection either directly or by antibody-mediated lysis of infected cells (Bradley et al., 2018; Ramsuran et al., 2018) . Although NK cells lack antigen-specific receptors, recent studies indicate that some responses are characterized by expansion and memory, features originally thought to be restricted to adaptive immunity. NK cells with a memory or adaptive phenotype may be particularly effective in cellular therapies targeting tumors or chronic viral infections (Cooper et al., 2018; O'Sullivan et al., 2015) .
In humans, circulating NK cells encompass two major subsets, known as CD56 dim and CD56 bright (Freud et al., 2017; Michel et al., 2016) . While this distinction is based on relative expression of the cell surface molecule CD56, profound functional differences exist between human NK subsets. CD56 dim cells predominate in blood, constituting $90% of circulating NK populations. This subset has higher cytotoxic activity than CD56 bright cells. Moreover, CD56 dim NK cells preferentially express the activating Fc receptor CD16, endowing them with a capacity for antibody-dependent cellular cytotoxicity (ADCC) (Nagler et al., 1989) . The CD56 dim NK population also encompasses two subsets, CD57 À and CD57 + , the latter of which has adaptive features and expands in response to human cytomegalovirus (HCMV) infection (O'Sullivan et al., 2015) . The minor CD56 bright population is more efficient than CD56 dim NKs in the production of cytokines, including IFNg, granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor alpha (TNF-a) (Freud et al., 2017; Michel et al., 2016) .
Circulating NK subsets also show considerable differences in homing molecules. CD56 bright cells express the chemokine receptor CCR7 and L-selectin, which drive their migration to secondary lymphoid organs (Fehniger et al., 2003) . In contrast, CD56 dim display a high density of CX3CR1 and CXCR1, which direct them into peripheral tissues. Interleukin (IL)-2 and IL-15 promote activation and proliferation of all NK cells. However, CD56 dim express the dimeric low-affinity receptor for IL-2 (CD122-CD132), whereas CD56 bright express the trimeric highaffinity IL-2R (CD25-CD122-CD132) (Allan et al., 2017) . In addition, the CD56 bright population expresses IL-7R and c-Kit, which may contribute to homeostatic proliferation. NK cell activation is controlled by inhibitory receptors specific for MHC class I, with CD56 dim selectively expressing the KIR and LILR families, whereas CD56 bright display CD94-NKG2A. Phenotypic and functional differences between CD56 dim and CD56 bright subsets have been extended further by gene arrays and proteomics (Hanna et al., 2004; Wendt et al., 2006) .
Developmental relationships between CD56 bright and CD56 dim NK cells remain unresolved; however, several studies indicate that the former is a precursor of the latter. An NK subset with intermediate features between CD56 bright and CD56 dim has been identified, corroborating this developmental trajectory (Freud et al., 2017; Yu et al., 2010) . However, CD56 dim also can convert into CD56 bright cells, at least in vitro, in the presence of activating cytokines (Keskin et al., 2007) . Several studies also have suggested that these subsets are terminally differentiated and arise from distinct precursors (Berrien-Elliott et al., 2015; Wu et al., 2014) .
Several nuclear factors have been implicated in the development and function of CD56 dim versus CD56 bright cells. Patients with mutations in the GATA2 transcription factor (TF) lack CD56 bright , but not CD56 dim NK cells, supporting a model for their independent development (Mace et al., 2013) . Mutations in the MCM4 gene, a DNA helicase associated with replication, specifically compromises the CD56 dim population (Gineau et al., 2012) . Despite these advances, little information exists on TF-orchestrated regulatory programs for functionally distinct human NK populations, information that will clearly be useful as NK-based cell therapies are optimized. We now report integrative analysis of enhancer and transcriptional landscapes for circulating human NK subsets compared to intra-epithelial innate lymphoid cells 1 (ieILC1), which reside in mucosal microenvironments and produce IFNg (Fuchs et al., 2013; Simoni et al., 2017) . Super-enhancer profiling identified novel genes that functionally specify the CD56 dim and CD56 bright subsets, including G-coupled protein receptors (G-PCRs), which may modulate human NK function in response to tissue-derived factors. Our analyses established parallels in function and homing potential between self-renewing T memory cells and the CD56 bright population, while the molecular programming of CD56 dim cells resembles that of effector T memory compartments. Importantly, key TFs governing these phenotypic modules comprise a regulatory scheme employed by both innate and adaptive lymphocytes for localization and effector function, which is evolutionarily conserved from humans to non-human primates and mice.
RESULTS

Transcriptional Programs of Human NK and ieILC1s from Distinct Microenvironments
To characterize the molecular programming for human NK and ieILC1 populations from distinct microenvironments, we initially compared transcriptomes of two circulating NK subsets, CD56 bright or CD56 dim , as well as tissue NK and ieILC1s derived from a mucosal-associated lymphoid tissue, the tonsil (Ts) ( Table  S1 ). Ts-NK and ieILC1 were defined as CD56 + NKp44 -CD94 + ( Figure 1A) , and CD56 + NKp44 + CD103 + , respectively (Koues et al., 2016) . Data for Ts-ILC3 were included for comparison with a distinct innate lymphoid lineage (Koues et al., 2016) . Classification of the various subsets was confirmed by expression patterns for signature genes, including NCAM1 (CD56), ITGAM (CD11b) for cytolytic NK, CD27 for IFNg-expressing NK (Fu et al., 2011) , ZNF683 (HOBIT), and ITGAE (CD103) for ieILC1 (Cortez et al., 2017; Weizman et al., 2017) ( Figure 1B ). Principle component analysis (PCA) of transcriptomes revealed a striking segregation of CD56 dim from the other subsets ( Figure 1C ). Transcriptional programs for the remaining three subsets formed a narrower spectrum of kinships, with Ts-NKs straddled by ieILC1 and CD56 bright cells. Inspection of individual genes further validated these relationships. For example, when comparing CD56 bright versus CD56 dim NK cells, nearly 300 genes were differentially expressed (>2.5-fold) ( Figure 1D ), while only 42 genes attained the 2.5-fold threshold in CD56 bright versus Ts-NK cells ( Figure 1E ). Numbers of significantly different genes in pairwise comparisons between all four NK-ieILC1 subsets are presented in Figure 1F , revealing a gradient of transcriptome kinships ranging from near identity (Ts-NK versus CD56 bright ) to clear divergence (ieILC1 versus CD56 dim ).
We next established the core set of signature genes expressed specifically in each NK or ILC1 subset. Because transcriptomes of Ts-and CD56 bright -NK cells were nearly identical, we limited core analyses to ieILC1, CD56 bright , and CD56 dim cells. As shown in Figure 1G , signature sets of genes ranged from $20 (CD56 bright ) to $160 for ieILC1. Relative expression of the signature genes are shown in Figures S1A-S1C. Ontology analysis of signature genes revealed that each NK-ieILC1 population was enriched for distinct functional categories, including cell migration, survival, IFNg production, and degranulation ( Figure S1D ). In addition to cohorts of expected genes, each signature had tantalizing features that suggested subset-distinctive biology. For example, the ieILC1 program included several genes normally expressed in ILC3s (e.g., RORC and IL23R), perhaps reflecting functional plasticity in the latter cell type, which can convert to ILC1s under certain conditions (Cella et al., 2010) .
In addition to overall differences between transcriptomes, 2-by-2-fold comparisons of all cell populations identified a limited cohort of genes for blood versus tonsil subsets, likely reflecting their distinct microenvironments ( Figure 1H ). Notably, Ts-NK and ieILC1 expressed CRTAM, encoding an adhesion molecule that facilitates tissue retention (Cortez et al., 2014) . Blood NKs expressed the gene for TGFBR3, which modulates transforming growth factor b (TGF-b) signaling and is distinctive from the classical TGFBR2 receptor that mediates TGF-b imprinting in ILC1s . Despite their divergence from other cell subsets, CD56 dim NKs shared a small set of genes that was also expressed by ieILC1s. This gene cohort includes those encoding a pair of NK cell receptors (TIGIT and CD160), suggesting that subpopulations of the two cell types can respond to similar cues. Together, transcriptome analyses established a spectrum of functional relationships between NK cells and ieILC1s in humans, as well as defined cohorts of genes that endow each with their specialized roles in innate immunity.
Expression Programs Reveal a Developmental Trajectory for Circulating NK Cells
Prior studies have shown that CD56 dim cells include two subsets, CD57and CD57 + , the latter of which expand in HCMV seropositive individuals and encompass ''adaptive'' NK cells (Lee et al., 2015; O'Sullivan et al., 2015; Schlums et al., 2015) . To probe developmental relationships between circulating NK subsets, we examined gene and protein expression profiles. Mass cytometry corroborated segregation of blood NK cells into three major subsets ( Figure 2A ), CD56 bright CD16 -CD57 -, CD56 dim CD16 + CD57 -(referred to as CD57 -), and CD56 dim CD16 + CD57 + (CD57 + ). Expression levels of proteins detected by a panel of 41 antibodies was used to probe developmental trajectories. Pseudotime analysis of CyTOF data predicted a developmental trajectory with two clear end-points: CD57 + and CD56 bright . The CD57population emerged as a transitional stage, with a mostly linear trajectory from the CD57 + population. However, a subset of CD57cells projected off this main pathway due to differential expression of IL-2R and/or NKG2A (Figures 2A and S2A) .
The protein-based developmental trajectory was further supported by gene expression. PCA of RNA sequencing (RNA-seq) data placed the transcriptome of CD57cells squarely between the CD56 bright and CD57 + populations ( Figure 2C ). Indeed, analysis of signature CD56 bright versus CD56 dim genes revealed a linear relationship, with CD57cells having intermediate (A) Strategy for CD56 bright versus CD56 dim (left) and tonsil NK (Ts-NK) sorting (right). (B) Heatmap highlighting differential expression of signature genes for NK-ieILC1 subsets. (C) PCA of genes with variable expression among CD56 bright , CD56 dim , Ts-NK, ieILC1, and ILC3. (D and E) Volcano plots showing significance and magnitude of expression changes between CD56 bright (red) and CD56 dim (blue) (D) or between CD56 bright (red) and Ts-NK (brown) (E). Colored genes highlight >2-fold differences that are statistically significant (p < 0.01, t test). (F) Number of transcripts differentially regulated when comparing two cell types (R2-fold change and p < 0.01, t test). (G) Total number of transcripts unique to CD56 bright , CD56 dim , and ieILC1 (R2-fold difference compared with other cell types). (H) Fold-change plot comparing gene expression in NK-ieILC1 populations. Colored circles represent transcripts expressed at least 2-fold higher in one subset versus another. Triangles represent transcripts expressed at least 2-fold higher in a single subset compared with all other three subsets. See also Figure S1 and Table S1. expression at the RNA and protein levels (Figures 2D, S2B, and S2C) . Pairwise comparison of gene expression data showed remarkable similarity between the CD57cells and CD56 bright populations, with more of a distinction between the CD57and CD57 + subsets (Figure 2E , F). Together, single-cell and bulk expression analyses uncovered a distant relationship between CD56 bright and CD57 + NK cells, which was largely bridged by the CD57subset.
Human NK Cell Regulomes
As an initial step in understanding mechanisms that drive distinctive aspects of NK cell expression programs, we subjected circulating NK subsets to epigenome analyses, which were compared with published data for tonsillar ieILC1 and ILC3 (Koues et al., 2016) . We identified locations of all active or poised regulatory elements using assay for transposase-accessible chromatin coupled with high throughput sequencing (ATAC-seq). We assessed relative enhancer activities using a chromatin immunoprecipitation (ChIP) sequencing assay for the histone modification H3K27ac, performed on bulk CD56 dim or CD56 bright populations. Initially, we focused on enhancers, classified as ATAC + regions, but excluding promoters, CTCF sites or regions
PRF1 r 2 =0.7 XCL1 r 2 =0.63 Colored genes highlight >2-fold differences that are statistically significant (p < 0.01, t test). (F) Number of transcripts differentially regulated when comparing two cell types (R2-fold change and p < 0.01, t test). See also Figure S2 and Table S1 . accessible in only a single replicate (Figure S3A) . Clustering analysis of either ATAC or H3K27ac data revealed consistent segregation of each cell population into unique branches, indicating negligible impact of donor diversity (Figures 3A and S3B) . Similar to gene expression, the accessible regulome of CD56 bright NK cells was closely related to the CD57subset ( Figure 3A , p < 0.05, bootstrapping analysis). We created a master list of ''hyper-accessible enhancers'' that reproducibly surpass a stringent cutoff for ATAC-seq signals (see STAR Methods) and identified elements that were differentially regulated in ILC populations ( Figure S3C ; Table S2 ). We reduced ATAC data for the hyper-accessible enhancers into two components by PCA ( Figure 3B ). The greatest contributor of variation, PC1, separated regulomes of blood NK versus tissue-resident ILCs. This segregation of regulomes is illustrated by blood NK-specific activity of an enhancer near the KLF3 transcriptional repressor ( Figure 3C ). PC2 separated cellular subsets primarily based on their cytotoxicity (CD57 + > CD57 -, ieILC1 > CD56 bright , ILC3). As an example, an enhancer neighboring the signature cytotoxicity gene, PRF1, exhibited a similar gradient of accessibility ( Figure 3D ). Other PC2-dominant loci associated with enhancers having the converse gradient of activities, including one situated proximal to an ILC3-enriched gene encoding leukemia inhibitory factor ( Figure S3D ) (Cella et al., 2010) . In all examples, gene expression tracked closely with the accessibility of highlighted enhancers (Figures 3C and 3D) , as well as H3K27ac loads for relevant cell populations. The transcriptional patterns were retained on a global level for ''hyper-accessible enhancers'' ( Figure S3E ). Thus, in addition to cell-type-selective elements, we identified two modules of chromatin activity and enhancers: one that distinguished human NK versus ILC subsets and a second that orchestrated expression programs for cytotoxicity.
We also used chromatin-based analyses to explore whether NK regulomes contribute to the etiology of human diseases, including autoimmunity. Indeed, the collection of active enhancers in all NK-ieILC1s was enriched for single nucleotide polymorphisms (SNPs) associated with immune system diseases but not with cancer or other non-immune traits ( Figure 3E ). Most of these SNPs were localized to enhancers active in all cell populations examined. However, SNPs associated with a susceptibility to tonsillar inflammation (Pickrell et al., 2016) were enriched only in ieILC1-active enhancers, consistent with their tissue origin ( Figure 3E ; Table S3 ). This finding indicates that the tonsillar microenvironment impacts a distinct set of enhancers in ieILC1s regulating genes involved in the magnitude of acute inflammatory responses. The major SNPs driving this enrichment in ieILC1-enhancers are associated with loci encoding IKZF1 (encoding IKAROS), NFKB1, and TNFSF13B (encoding BAFF). The disease-associated SNP in TNFSF13B ( Figure 3F ) is predicted to disrupt an enhancer binding site for the GATA family of TFs, which may reduce BAFF expression.
A second category of differential SNP enrichment is associated with inflammatory bowel diseases (IBD), and localize to enhancers with preferential activity in ieILC1 and CD56 dim NK cells (Table S3 ). A major driver of this enrichment was a set of SNPs in IKZF3 (Aiolos), whose expression pattern parallels the aforementioned enhancer activity ( Figure 3F ). Thus, the IKZF3-associated SNP may alter expression of this repressive TF in ieILC1 and CD56 dim NK cells, contributing to initiation or progression of IBD. Our analyses suggest that enhancer-associated DNA variants may contribute to inflammatory autoimmune diseases via changes in NK gene expression. Figure S3 and Table S2 .
Super-Enhancers Identify Novel NK Signaling Pathways
Highly transcribed genes that endow cell type functions are often associated with dense enhancer regions, termed superenhancers (SEs) (Hnisz et al., 2013) . These broad, hyperactive regulatory regions are assigned an SE status based on their extreme breadth and density of H3K27ac (Koues et al., 2016) . In addition to transcriptional regulation, SEs can serve as discovery tools for genes with critical functions in a given cell type. We applied an SE detection algorithm to our ChIP data as a means of identifying core genes for CD56 bright and CD56 dim NK populations, which were compared with previously published ieILC1 SEs (Koues et al., 2016) . Several SE-associated genes are highlighted in Figures 4A and S4, including TFs (e.g., PRDM1, RUNX2, TCF7, BACH2, PLZF), cell surface receptors (e.g., TGBR2), and signaling molecules (e.g., PRKCH, CD247). As expected, genes associated with SEs called specifically in one of the three cell types correlated with their higher levels of expression ( Figure 4B ). Furthermore, a substantial fraction of SEs and associated gene expression were conserved between human and mouse NK subsets ( Figures 4C and S4B-S4E ).
Most of the SEs were specific to only one or two NK-ieILC1s ( Figure 4D ). For example, an NK-specific SE spanned NMUR1, encoding a G-PCR for the neuropeptide neuromedin U, which is expressed in NK cells but not ieILC1s ( Figure S4C ). Given the increasing appreciation of crosstalk between neural and immune systems (Veiga-Fernandes and Artis, 2018), NMUR1 is an attractive target for future functional studies in NK subsets. More globally, SE analysis identified a collection of G-PCR genes with a wide variety of expression profiles (Table S4 ). The G-PCR encoded by CMKLR1 is covered by an SE only in CD56 dim NK cells ( Figure S4D ), correlating with its cell-type-restricted expression. This chemokine receptor promotes egress of CD56 dim NK cells to sites of tumor-associated inflammation in response to chemerin (Pachynski et al., 2012; Parolini et al., 2007) . A second CD56 dim -specific SE spans GPR141, which encodes a conserved G-PCR with unknown ligands or function, but with a potentially important role in NK biology ( Figure S4E ). As shown in Figure 4E , the locus encompassing GPR18 and GPR183 was covered by an SE in CD56 bright and ieILC1s but not in CD56 dim NK cells, again correlating with gene expression. See also Figure S4 and Table S4 .
GPR183, also known as EBI2, is a receptor for oxysterols with roles in lymphocyte trafficking and inflammatory cytokine expression (Emgå rd et al., 2018) . To test whether CD56 bright cells were responsive to the GPR183 ligand, 7a,25-dihydroxycholesterol (7a,25-dhc), we cultured this NK subset in the activating cytokines IL-12+IL-18, either with or without 7a,25-dhc. As shown in Figure 4F , the GPR183 ligand attenuated IFNg production by CD56 bright NK cells. Thus, SE analysis provides a discovery tool to identify novel genes with functions in NK cells.
Transcription Factors that Control NK-ieILC1 Regulomes
To understand how ILC-NK subsets coordinate the activation and repression of distinct enhancer and SE collections, we analyzed differentially regulated cis-elements for enrichment of TF motifs. This agnostic approach yielded a similar set of enriched motifs whether accessibility (ATAC-seq) or activation (H3K27ac-seq) data were fed into the HOMER algorithm (see STAR Methods). As shown in Figures 5A and S5A , differentially active enhancers appear to be targeted by TF families that distinguish each NK-ieILC1 subset or are shared specifically by all NK populations. When paired with gene expression ( Figure S5B ), single members of a TF family usually correlated with motif utilization ( Figure 5A ). Comparisons between ieILC1 and NK cells identified enhancers with preferential ieILC1 activity that were significantly enriched for motifs predicted to bind SMAD transcription factors, which mediate TGF-b imprinting. When compared with ieILC1s, active enhancers in circulating NK subsets were enriched for T-box motifs, which are targets of the type 1 ''master regulators'' T-BET and EOMES (Gordon et al., 2012) . Moreover, NK subsets were enriched for co-occurring T-box and RUNX motifs within individual enhancers ( Figure S5C) ; a finding supported further by publicly available ChIP-seq data (Table S5 ). As one example, an evolutionarily conserved RUNX+T-box enhancer was located near the SELL gene, which encodes CD62L, and was more accessible in CD56 bright NK. The enhancer was bound by both RUNX3 and T-BET in a human B cell line and by T-BET in primary mouse NK cells ( Figure 5B ). The collection of enhancers that display preferential activity in CD56 bright NK cells were enriched for RUNT, HMG, PRDM1, E-box, and NFKB motifs ( Figure 5A ). RUNT motifs are targeted by RUNX family members, which are important players in lymphocyte biology (Collins et al., 2009) . Although RUNX1 and RUNX3 were expressed in all blood NK subsets, RUNX2 was (F) A representation of CD56 bright and CD56 dim NK transcription factor regulatory circuits, as predicted from combined expression and motif analysis. Also included are key effector genes of both subsets. See also Figure S5 and Table S5. highly restricted to CD56 bright cells at the RNA and protein levels ( Figures 5A and S2B) . These data suggest that a distinctive set of enhancers were activated in the CD56 bright compartment either because they were unique targets of RUNX2 or required levels of total RUNX family proteins that were surpassed when this additional member was expressed. Consistent with the latter possibility, there were no identifiable differences in RUNX motifs for CD56 bright -specific enhancers versus those shared with CD56 dim cells ( Figure S5C ). Preferential use of HMG motifs in CD56 bright cells likely corresponds to their enhanced expression of TCF7 and LEF1 ( Figure 5A) , two homologous TFs with some functional overlap (Held et al., 2003) . Both of these HMG family proteins have been implicated in self-renewal programs of memory T and hematopoietic stem cells, and therefore may control homeostatic proliferation of CD56 bright NK cells . Importantly, NK-specific deletion of Tcf7 in mice leads to defects in NK cell survival (Jeevan-Raj et al., 2017) . In this context, CD56 bright accessibility was enriched at TCF1 ChIP-seq peaks from K562 cells ( Figure S5D ). This included two regulatory elements near MYC, which is expressed at higher levels in the CD56 bright subset, and is known to coordinate programs for cell proliferation, survival, and biomass production ( Figure 5C ). Indeed, CD56 bright NK had higher levels of total RNA per cell than the MYC À CD57 + NK population ( Figure 5D ). Consistent with their transitional status and intermediate levels of MYC expression, CD57 À cells had intermediate levels of total RNA. These findings were confirmed by RNA-seq using external ERCC spike-ins for normalization (Chou et al., 2014) .
Motif analysis also revealed that the CD56 bright molecular program is suppressed in CD57 + NK cells via expression of several transcriptional repressors ( Figure 5A) . Specifically, the PRDM1 motif was enriched in active enhancers of CD56 bright NK cells. This finding is supported by differential expression of PRDM1, which encodes the BLIMP1 repressor-high in CD56 dim (enhancer repression) and low in CD56 bright (not repressed). Importantly, BLIMP1 silences genes associated with lymphoid self-renewal and survival, including MYC and IL7R (Kü ç ü k et al., 2011), and is required for mouse effector NK development (Kallies et al., 2011) . The other TF that binds PRDM1 motifs is ZNF683 (HOBIT). However, ZNF683 expression is restricted to ieILC1, reflecting its known function in tissue residency (Mackay et al., 2016) . Another repressor, BACH2, enforces a self-renewal program in T memory cells via repression of BLIMP1 and downstream effector pathways (Herndler-Brandstetter et al., 2018) . Indeed, BACH2, which binds a PRDM1 enhancer, is preferentially expressed in CD56 bright cells, where BLIMP1 is extinguished ( Figures 5A and S5E) .
Transcripts for the ZEB2 repressor were elevated in both CD56 dim subsets. Gene set enrichment analysis (GSEA) confirmed preferential expression of ZEB2 ( Figure 5E ) and PRDM1 ( Figure S5F ) targets in CD56 bright NK cells (Dominguez et al., 2015) , in which these repressors were not expressed. As an example, the gene encoding CCR7, a chemokine receptor that promotes homing of CD56 bright into lymph nodes, is flanked by an enhancer that was attenuated in CD56 dim cells, corresponding to their expression of the ZEB2 repressor. The same regulatory element is bound by ZEB2 in K562 cells, in which this enhancer is silent ( Figure 5E ). In addition to repressor bind-ing, the collection of enhancers specifically augmented in CD56 dim cells were enriched for bZIP motifs, which can facilitate either transcriptional activation or repression. Two members of the bZIP family, MAF and NFIL3, were expressed at higher levels in CD56 dim versus CD56 bright NK cells ( Figure 5A ). These TFs have been implicated in helper T cell differentiation (Gabry sová et al., 2018) and NK cell responsiveness to IL-15 (Firth et al., 2013) , respectively. Importantly, CD56 dim populations require expression of MCM complex genes, some of which are under MAF control ( Figure S5F ) (Chihara et al., 2018) .
Together, integrative -omics profiling of human blood NK populations defined a TF-based regulatory scheme for maintaining transcriptional identities of CD56 bright versus effector CD56 dim cells ( Figure 5F ). In brief, CD56 bright phenotypes are positively coordinated by TCF1-LEF1 and MYC, while BACH2 represses effector phenotypes associated with CD56 dim NK cells. Conversely, BLIMP1 and ZEB2 suppress the CD56 bright features at the CD56 dim stage, while MAF, and likely other TFs, coordinate expression of major effector genes.
A Conserved Regulatory Network of TFs for Lymphoid Cells
The counterbalance of positive and negative transcriptional regulation orchestrating NK phenotypes, as well as the identity of responsible TFs, bears a striking resemblance to regulatory strategies that compartmentalize self-renewal, localization, and effector functions in other lymphoid lineages. An excellent example of this potentially conserved regulatory paradigm is in the CD8 T cell memory compartment. Similar to CD56 bright NK cells, self-renewing CD8 memory cells (T stem cell memory [T SCM ] and T central memory [T CM ]) transit between blood and lymph node and co-express TCF1 and BACH2 (Herndler-Brandstetter et al., 2018) . By analogy to CD56 dim NK cells, effector and effector memory (T EM ) CD8 subsets are highly cytotoxic and coexpress BLIMP1 and MAF (Im et al., 2016) .
To explore more comprehensively the parallel between human subsets, we compared our NK and publicly available CD8 transcriptome data (Araki et al., 2009; Gattinoni et al., 2011) . Indeed, CD56 bright NK, T SCM , and T CM had strikingly similar expression profiles, which were also related to the naive CD8 T cell transcriptome ( Figures 6A and 6B) . In contrast, gene expression programs of CD57 + NK cells most significantly overlap with the T EM subset. These parallels also were observed at the chromatin level. Promoters that were differentially accessible in CD56 bright NK cells had higher levels of the activating H3K4me3 modification in naive CD8 T cells, but were hypomethylated in T EM ( Figure 6C ). The converse was true for accessible CD57 + promoters. These integrative analyses revealed a unifying regulatory strategy deployed by both innate and adaptive lymphocytes in humans.
To determine whether this regulatory scheme is evolutionally conserved, we examined mouse NK and CD8 T cell subsets. NK cell development in mice proceeds from a poorly cytotoxic precursor (CD11b À , CD27 + ), through a double positive intermediate (CD11b + CD27 + ), terminating in a poorly proliferative, cytotoxic NK cell (CD11b + CD27 À ) ( Figure S6A) (Chiossone et al., 2009 ). Initially, we compared transcriptomes of human blood and mouse splenic NK subsets, as well as mouse CD8 memory T cells (Best et al., 2013; Heng et al., 2008) . As shown in Figure 6A , expression of key genes corroborated parallels between the precursor-like populations in human and mouse (CD56 bright , CD11b -CD27 + NK, T CM ), including the master regulatory TFs, Tcf7-Lef1 and Myc. Human effector NK cells (CD57 + ) were most similar to the mouse CD11b + subset and T EM . These overall patterns were confirmed by GSEA of differentially expressed genes in mouse and human ( Figure 6D ). In addition, core genes in the regulatory scheme were differentially expressed in sorted NK subsets from macaques (Hong et al., 2013) , further underscoring the evolutionarily conservation of this paradigm ( Figure S6B ).
We also found similarities between human blood and mouse splenic NK subsets at the regulome level. Globally, the set of evolutionarily conserved enhancers specific for CD56 bright NK cells was preferentially active in the mouse CD27 + CD11bsubset ( Figure 6E ), while the converse was true for enhancers active in circulating CD56 dim NK cells. Indeed, enhancers distinguishing human CD56 bright versus CD56 dim subsets that were conserved in their mouse counterparts exhibited an enrichment for the expected TF motifs ( Figure S6C ). Many of the conserved enhancers with differential activity were proximal to genes identified in the core set of signature transcripts shown in Figure 5A . For example, the TCF7 locus contained three CD56 bright -specific enhancers that were conserved evolutionarily and were accessible in the CD27 + CD11bsubset ( Figure 6F ). Strikingly, one enhancer bound the repressor BLIMP1 in splenic CD8 T cells (Mackay et al., 2016) , likely attenuating its activity in mature subsets from both mouse and human ( Figure 6D ). Together, comparative transcriptome and epigenome analyses revealed an evolutionarily conserved regulatory scheme that spans at least two lymphoid lineages and coordinates expression of genes responsible for precursor-like or effector phenotypes.
DISCUSSION
The collection of IFNg-producing innate lymphocytes, which are important for controlling microbial infections and transformed (D) GSEA enrichment of genes selectively expressed in CD27 + CD11b À (left) or CD27 À CD11b + (right) cells from Heng et al. (2008) showing relative levels in CD56 bright and CD56 dim NK transcriptomes. (E) Overlap between conserved CD56 bright and CD56 dim cell-type selective enhancers with either CD27 + CD11b À or CD27 À CD11b + ATAC peaks. (F) UCSC screenshots of the human (top) and mouse (bottom) TCF7 locus showing ATAC or H3K4me3 data from indicated cell type. The bottom track for mouse data shows ChIP-seq data for BLIMP1 from mouse CD8 cells. See also Figure S6 . cells, display a wide range of functional phenotypes in both humans and mice (Cortez and Colonna, 2016) . In mouse, these cells can be grouped phenotypically as helper ILC1s versus cytotoxic NK, which diverge as separate lineages (Constantinides et al., 2015; Klose et al., 2014) . In humans, however, functional and lineage relationships between ILC1s and subsets of NK cells, including those found in blood, are not as well defined (Freud et al., 2017; Michel et al., 2016) . Given the high priority status of NKs in cell-based therapies for cancer, we require a deeper understanding of the regulatory modules controlling phenotypes for clinical efficacy, such as cytotoxicity, IFNg production, homing, proliferation, self-renewal, and memory.
Our studies approached this problem using integrative -omics analysis of human NK-ieILC1s from distinct microenvironments and functional subsets, including helper and adaptive phenotypes. At both the transcriptional and epigenetic levels, we find that the adaptive subset, CD57 + cytotoxic NK cells, segregated away from a spectrum of more closely related subsets (CD57 -, CD56 bright , tonsillar NK, and ieILC1s). Beyond this, a small set of signature genes distinguished the five subsets from one another, with a substantial mixing and matching of transcriptional modules to create patchwork expression programs. For example, RUNX2, an osteoblast-restricted gene, was selectively expressed in CD56 bright NK cells (Komori, 2010) . KLF3, originally thought to be an erythrocyte TF (Crossley et al., 1996; Vu et al., 2011) , was selectively expressed in circulating NK cells, but not those found in mucosal tissue. Unexpectedly, circulating CD56 dim NK cells shared a small set of genes with ieILC1s residing in a mucosal microenvironment, further underscoring the patchwork nature of NK-ieILC1 expression programs. Although additional studies are required, the CD56 dim -ieILC1 shared module may derive from a unique combination of TF expression that includes ZNF683 (HOBIT, ieILC1), PRDM1 (BLIMP1, CD56 dim ), and IKZF3 (AIOLOS, both).
A major finding to emerge from this study is a conserved regulatory scheme deployed by both innate and adaptive lymphocytes, which is coordinated by a cohort of TFs. The scheme functionally compartmentalizes effector cells that circulate between blood and peripheral tissues from self-renewing precursors that traffic to lymph nodes. The latter regulatory scheme utilizes the transcriptional activators TCF1-LEF1 and MYC in NK (CD56 bright ), T memory, and T naive compartments. Moreover, human B, T, and NK cells suppress effector pathways via expression of BACH2, which may be under the control of AHR signaling (Richer et al., 2016) . The BACH2-mediated brake appears to be released in all of these cells upon expression of BLIMP1, which feeds back to repress the TCF1-LEF1 and MYC module, while effector programs are activated by MAF. In support of this unified model, TCF1 promotes renewal and maintenance of hematopoietic stem cells , T SCM , which exhibit a heightened capacity to undergo IL-7and IL-15-driven homeostatic proliferation (Gattinoni et al., 2011) , CD4 + T follicular helper cells (Choi et al., 2015) , and Ly49H + MCMV-specific naive and memory NK cells (Lau et al., 2018) . With regard to translational implications, TCF1 also is expressed in a subset of CXCR5 + CD8 + T cells that proliferate in response to anti-PD1 treatments for chronic infection and cancer (Im et al., 2016) .
In contrast, TCF7-LEF1 were both poorly expressed in the adaptive CD56 dim CD57 + NK subset, which exhibits a more terminally differentiated state reminiscent of CD8 + T EM and CD4 + TH1 cells (Choi et al., 2015; Herndler-Brandstetter et al., 2018) . Our analyses identified conserved enhancers in TCF7 and LEF1 loci that are targeted by BLIMP1 in differentiated mouse cells, likely repressing their expression. A similar switch is governed by these TFs in mouse counterparts of human NK subsets, as well as in macaques, a non-human primate. The parallels between regulatory programs in NK and T cells may extend to additional TFs. Specifically, we observed a reciprocity between ZEB1 and ZEB2 expression in proliferative precursors (CD56 bright , T SCM , T CM ) and effector cells (CD56 dim , T EM ), respectively (Guan et al., 2018) .
Our integrative and single cell analyses revealed potential developmental relationships between circulating human NK cells. Transcriptome, epigenome and protein expression data displayed gradients of activity from CD56 bright to CD57 À transitional cells to the CD57 + NK subset. This trajectory is consistent with some reports indicating that CD56 bright cells can serve as precursors to the CD56 dim subset (Freud et al., 2017; Yu et al., 2010) . Thus, the TCF7-LEF1-MYC module in CD56 bright NKs may function to preserve progenitor populations, which can continually replenish CD57 + adaptive cells following induction of BLIMP1. However, we do not exclude alternative cause-effect relationships between transcriptional modules, especially since fate mapping studies of NK cells are not possible in humans. Distinct expression programs may reflect homing potential or localization of NK subsets, rather than a discrete developmental pathway. In support of this scenario, all cells sharing the TCF1-LEF1-MYC module, including naive CD8 T cells, traffic between the blood and secondary lymphoid organs, as indicated by expression of CD62L and CCR7. Indeed, we found that expression programs of tonsillar NK cells were nearly indistinguishable from the CD56 bright subset. In contrast, CD56 dim NK and T EM cells, which share the BLIMP1-MAF module, traffic between blood and non-lymphoid organs. Consistent with recent studies, a third regulatory module driven by the TF HOBIT (ZNF683) appears to drive retention of ieILC1 and resident memory T cells (T RM ) in a variety of tissues (Jameson and Masopust, 2018) .
Our approach, including the characterization of histone modifications in scarce NK subsets, allowed us to identify super-enhancers, which associate with genes endowing a given cell type with its unique identity (Hnisz et al., 2013) . Especially intriguing were SEs with distinct activities in NK subsets, such as those proximal to a substantial set of G-PCRs. Given the role of G-PCRs in transmitting microenvironmental cues, the distinctive set of receptors may govern migration of circulating NK cells to different tissues, expression of cytokines, cytotoxic responses, or CD56 bright to CD56 dim differentiation. Indeed, the cholesterol metabolite 7a,25-dhc, which is produced by virally infected cells (Blanc et al., 2013; Cyster et al., 2014) , attenuated IFNg expression by CD56 bright NK cells, presumably through their high levels of GPR183 expression. Consistent with IFNg inhibition, GPR183 signals through G ai to inhibit cAMP production (Rosenkilde et al., 2006) . Additionally, an NK-restricted SE coats the NMUR1 gene, suggesting that its continued expression may be important for CD56 bright and CD56 dim NK functions, perhaps by enabling communication with the peripheral nervous system (Veiga-Fernandes and Artis, 2018) . A number of G-PCRs (e.g., GPR141) and other SE-associated genes emerging from our data remain uncharacterized, especially with regard to their functions in NK cell biology, thus providing a valuable resource for future studies.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Anti-NKp44 AlexaFluor647 (RRID: AB_647153) BDPharmingen Cat#558564
Anti-CD103 BV605 (RRID: AB_2564283) Biolegend Cat#350218
Anti-CD94 PE-Cy7 (RRID: AB_2632752) Biolegend Cat#305515
Anti-H3K27ac (RRID: AB_2118291) Abcam Ab4729
Anti-CD3 FITC (RRID: AB_314060) Biolegend Cat#300406
Anti-CCR6 BV421 (RRID: AB_2561356) Biolegend Cat#353408
Anti-CD3 PerCP-Cy5.5 (RRID: AB_1518743) eBioscience Cat#45-0036
Anti-CD19 PerCP-Cy5.5 (RRID: AB_2043821) eBioscience Cat#45-0199
Anti-CD94 FITC (RRID: AB_314534) Biolegend Cat#305504
Anti-NKp44 PE (RRID: AB_647239) BDPharmingen Cat#558563 peaks or super enhancers using ChIPSeeker (Bioconductor), and analyzed for differential enhancer activities. For conservation analysis, conserved regions were identified using CrossMap and BEDTools. SNP Analyses SNP annotation of enhancer regions was accomplished using TraseR (Bioconductor) and plotted with Prism software (GraphPad). Predictions for TF motif disruption were generated by HaploReg (Broad Institute).
Figure Compilation
Figures were compiled using Microsoft PowerPoint. Low resolution text or UCSC snapshot gene representations were cropped and replaced using PowerPoint. Heatmaps for either motif enrichment or the expression data appended to the right of UCSC snapshots were first generated using Morpheus (Broad Institute), then copied into PowerPoint boxes using color matching tools.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis of primary data were performed with R or Prism software (GraphPad). For statistical comparisons between two groups (data from cytokine bead arrays, volcano plots, pairwise ATAC-, H3K27ac-and RNA-seq comparisons), we used Student's 2-tailed t test. Data are expressed as mean ± SD and significance levels are indicated in the figure legends. For comparisons between multiple groups (expression, ATAC-and H3K27ac-seq), data were first filtered to include only genes or enhancers with signals above a minimum threshold in multiple replicates using KOverA() from the R package GeneFilter (Bioconductor). Significance at the 0.001 threshold was then determined by ANOVA using row.oneway.anova() from the R package HybridMTests (Bioconductor). Significantly enriched genes or enhancer values (probe intensities or normalized reads) were then subjected to hierarchical clustering and PCA using R libraries. PCA was plotted using the R package, ggplot2. For hierarchical clustering, data were first converted into distances using as.dist(1-cor()), then clustered using hclust(,method = ''ward.D'').'' Colors based upon K-means clustering were assigned using the R package, dendextend. Gene set enrichment in various NK subsets and significance values were determined using GSEA (Broad Institute). Overlaps between enriched gene sets for CD8 and NK subsets was determined by a binomial distribution, using the R function pbinom().
For TF motif analysis, enhancers were assigned as differentially active if quantile normalized RPKMs for either ATAC or H3K27ac data were significantly enriched in one cell type by more than two-fold, when compared with another cellular subset (Student's t test, p < 0.01). Centers of ATAC peaks (200 bp) were extracted from differentially active enhancers and analyzed by HOMER using findMotifsGenome.pl with default settings. Significance was determined using Homer's binomial distribution reporting and only significant motifs are presented (p < 0.001).
Supplemental Figures
(legend on next page) Figure S1 . Additional Expression Analysis of Human NK and ILCs, Related to Figure 1 (A-C) Transcripts unique to (A) ieILC1, (B) CD56 bright , or (C) CD56 dim . The transcript list was curated to include only those expressed at > 2 6 relative and > two-fold relative the other two cell types. Heatmaps show average probe intensity of transcripts across replicates. (D) GO enrichment of genes preferentially expressed in either ieILC1, CD56 bright or CD56 dim subsets. Relative significance levels were normalized between row minimum (blue) and row maximum (red). IL-7R 10 4 10 3 0 CX3CR1 CXCR2 10 1 10 5 10 2 10 5 10 4 10 3 10 2 0 CD27 10 5 10 4 10 3 10 2 0 TIGIT 10 5 10 4 10 3 10 2 0 GATA3 10 5 10 4 10 3 10 2 0 RUNX2 10 5 10 4 10 3 10 2 0 S100A4 10 5 10 4 10 3 10 2 0 IL18R 10 5 10 4 10 3 10 2 0 CD62L 10 5 10 4 10 3 10 2 0 10 4 10 3 0 1 0 1 10 2 10 0 CCR7 10 5 10 4 10 3 0 1 0 1 10 2 10 0 FGFBP2 10 5 10 4 10 3 0 1 0 1 10 2 10 0 TCF1 10 5 AHR BCL11B  IKZF3  KLF2  KLF3  BNC2  PLEK  PRDM1  MAF  ZEB2  MYBL1  JAZF1  ZBTB16  TBX21  KLF4  MEF2C  BACH2  TCF7  ZEB1  RUNX2  MYC  AHR  SOX4  AFF3  IRF8  TCF4  EOMES  LEF1  ZNF140  RBPJ  DPF3  RORC  ELK3  ZNF75D  PHTF2  ZNF683 CD56+  CD56+  CD56+  CD56+  DN  DN  DN  DN  CD16+  CD16+  CD16+  CD16+   BLIMP1  T-BET  LEF1  TCF7  GATA3 min max Figure S6 . Additional Analysis of Conserved NK Cell Expression and Chromatin Patterns, Related to Figure 6 (A) GO enrichment of genes preferentially expressed in either CD27 + CD11bor CD11b + subsets. Enrichment categories under significance level, after adjusting for multiple comparison, are not shown (B) Expression of select genes (Hong et al., 2013) in rhesus macaque NK cell populations (blue: low, red: high). (C) Motif utilization for enhancers differentially regulated between CD56 bright and CD56 dim NK (p < 0.05, Student's t test) and conserved in the corresponding mouse NK subsets (peaks present in orthologous regions of both species) based on ATAC data.
